Jonas Herzberg
Research Subjects
Jonas Herzberg has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Tim Strate
Krankenhaus Reinbek St. Adolf‐Stift Reinbek Germany
19 shared publicationsHuman Honarpisheh
Department of Surgery, Krankenhaus Reinbek St. Adolf-Stift, Reinbek, Germany
17 shared publicationsSalman Yousuf Guraya
Clinical Sciences Department, College of Medicine University of Sharjah Sharjah United Arab Emirates
17 shared publicationsAnn-Kristin Becker
Department of Surgery – Krankenhaus Reinbek St. Adolf-Stift, Reinbek, Germany
9 shared publicationsBastian Fischer
Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany
9 shared publicationsCornelius Knabbe
Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany
9 shared publications
Latest Publications
- Open Access
Surgical Outcomes of Hybrid-Robotic Compared with Non-Robotic Oncological Esophagectomy for Adenocarcinoma Using a Fail-Safe Protocol—A Cohort Study
Background: Ivor Lewis esophagectomy for esophageal malignancies is a core element of the treatment but still comes with substantial postoperative complications. Especially within the learning curve of robotic esophagectomy, an optimal treatment pathway is crucial to minimize the clinical impact of this phase. This study aimed to compare the surgical outcomes of hybrid-robotic esophagectomy for adenocarcinoma of the esophagus with non-robotic procedures using a fail-safe protocol. Methods: This retrospective single-center study evaluated the outcome of hybrid-robotic procedures within the early robotic learning curve in comparison to a historical control group of laparoscopic and open non-robotic procedures using uni- and multivariable regression analysis. CUSUM analysis was applied for learning curve outcomes. All procedures were performed between January 2016 and December 2025 within a standardized fail-safe approach. The primary end point was the occurrence of anastomotic leakage (AL), whereas the overall complications as well as the number of harvested lymph nodes were secondary end points. Results: A total of 156 patients were analyzed, including 50 hybrid-robotic and 106 non-robotic resections. Robotic surgery was associated with a higher lymph node yield (40.9 ± 11.0 vs. 35.7 ± 13.1; p = 0.011) and a lower lymph node ratio (0.085 vs. 0.125; p = 0.046). The AL rate was 4.0% in the robotic group and 5.7% in the non-robotic group. Length of stay was significantly shorter after robotic procedures (13.1 ± 5.5 vs. 18.6 ± 11.3 days; p < 0.001). Conclusions: Establishing a robotic esophagectomy program within an established structured fail-safe protocol was not associated with an increased risk of anastomotic leakage or major complications. Within this standardized setting, an increased lymph node yield, potentially optimizing oncological quality was observed. These findings indicate that acceptable preoperative safety and oncological outcomes can be achieved even during the learning curve of hybrid-robotic esophagectomy embedded in a structured fail-safe protocol.
Open AccessSurgical Outcomes of Hybrid-Robotic Compared with Non-Robotic Oncological Esophagectomy for Adenocarcinoma Using a Fail-Safe Protocol—A Cohort Study
Background: Ivor Lewis esophagectomy for esophageal malignancies is a core element of the treatment but still comes with substantial postoperative complications. Especially within the learning curve of robotic esophagectomy, an optimal treatment pathway is crucial to minimize the clinical impact of this phase. This study aimed to compare the surgical outcomes of hybrid-robotic esophagectomy for adenocarcinoma of the esophagus with non-robotic procedures using a fail-safe protocol. Methods: This retrospective single-center study evaluated the outcome of hybrid-robotic procedures within the early robotic learning curve in comparison to a historical control group of laparoscopic and open non-robotic procedures using uni- and multivariable regression analysis. CUSUM analysis was applied for learning curve outcomes. All procedures were performed between January 2016 and December 2025 within a standardized fail-safe approach. The primary end point was the occurrence of anastomotic leakage (AL), whereas the overall complications as well as the number of harvested lymph nodes were secondary end points. Results: A total of 156 patients were analyzed, including 50 hybrid-robotic and 106 non-robotic resections. Robotic surgery was associated with a higher lymph node yield (40.9 ± 11.0 vs. 35.7 ± 13.1; p = 0.011) and a lower lymph node ratio (0.085 vs. 0.125; p = 0.046). The AL rate was 4.0% in the robotic group and 5.7% in the non-robotic group. Length of stay was significantly shorter after robotic procedures (13.1 ± 5.5 vs. 18.6 ± 11.3 days; p < 0.001). Conclusions: Establishing a robotic esophagectomy program within an established structured fail-safe protocol was not associated with an increased risk of anastomotic leakage or major complications. Within this standardized setting, an increased lymph node yield, potentially optimizing oncological quality was observed. These findings indicate that acceptable preoperative safety and oncological outcomes can be achieved even during the learning curve of hybrid-robotic esophagectomy embedded in a structured fail-safe protocol.
- 3 October 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (1) , 157-158
Efficacy of laparoscopic‐installed rectus sheath block for postoperative pain reduction in transabdominal preperitoneal inguinal hernia repair: a reply
- 3 October 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (1) , 157-158
Efficacy of laparoscopic‐installed rectus sheath block for postoperative pain reduction in transabdominal preperitoneal inguinal hernia repair: a reply
- 14 July 2025
- Published by Wiley in Anaesthesia
Efficacy of laparoscopic‐installed rectus sheath block for postoperative pain reduction in transabdominal preperitoneal inguinal hernia repair: a double‐blind, randomised‐controlled trial
Summary: Introduction: Postoperative pain management plays a crucial role in early recovery after laparoscopic inguinal hernia repair, particularly as most repairs are done as day‐case surgery. The aim of this study was to evaluate the anaesthetic effect of a laparoscopically‐guided rectus sheath block on postoperative pain.Methods: Within this prospective, double‐blinded, randomised controlled trial, patients planned for inguinal hernia repair using the transabdominal preperitoneal patch plastic were recruited. Patients were assigned randomly to either a control group or an intervention group. Both received standardised pre‐emptive anaesthesia during the surgical procedure with self‐fixating mesh. In the intervention group, an intra‐operatively implemented rectus sheath block was performed for postoperative pain control. The primary outcome was the postoperative pain score 3 h after surgery.Results: Thirty‐five patients were included in the study; 17 patients were randomised to the intervention group and 18 to the control group. Patient demographics and procedural times were similar in both groups. Postoperative median (IQR [range]) pain scores were not significantly different between the groups 3 h after surgery (intervention group 3.0 (3.0–5.0 [1.0–8.0]) vs. control group 3.5 (2.25–4.75 [1.0–8.0]); p = 0.854). The median (IQR [range]) oxycodone requirement after surgery was not different between the groups (intervention group 0 (0–3 [0–7]) mg vs. control group 0 (0–3 [0–7]) mg; p = 0.869).Discussion: This study has shown that a laparoscopic rectus sheath block has no beneficial effect in postoperative pain management following laparoscopic transabdominal inguinal hernia repair.
- 14 July 2025
- Published by Wiley in Anaesthesia
Efficacy of laparoscopic‐installed rectus sheath block for postoperative pain reduction in transabdominal preperitoneal inguinal hernia repair: a double‐blind, randomised‐controlled trial
Summary: Introduction: Postoperative pain management plays a crucial role in early recovery after laparoscopic inguinal hernia repair, particularly as most repairs are done as day‐case surgery. The aim of this study was to evaluate the anaesthetic effect of a laparoscopically‐guided rectus sheath block on postoperative pain.Methods: Within this prospective, double‐blinded, randomised controlled trial, patients planned for inguinal hernia repair using the transabdominal preperitoneal patch plastic were recruited. Patients were assigned randomly to either a control group or an intervention group. Both received standardised pre‐emptive anaesthesia during the surgical procedure with self‐fixating mesh. In the intervention group, an intra‐operatively implemented rectus sheath block was performed for postoperative pain control. The primary outcome was the postoperative pain score 3 h after surgery.Results: Thirty‐five patients were included in the study; 17 patients were randomised to the intervention group and 18 to the control group. Patient demographics and procedural times were similar in both groups. Postoperative median (IQR [range]) pain scores were not significantly different between the groups 3 h after surgery (intervention group 3.0 (3.0–5.0 [1.0–8.0]) vs. control group 3.5 (2.25–4.75 [1.0–8.0]); p = 0.854). The median (IQR [range]) oxycodone requirement after surgery was not different between the groups (intervention group 0 (0–3 [0–7]) mg vs. control group 0 (0–3 [0–7]) mg; p = 0.869).Discussion: This study has shown that a laparoscopic rectus sheath block has no beneficial effect in postoperative pain management following laparoscopic transabdominal inguinal hernia repair.
- Open Access
Effect of Preoperative Body Composition on Postoperative Anastomotic Leakage in Oncological Ivor Lewis Esophagectomy—A Retrospective Cohort Study
Background: Surgery for esophageal cancer has an associated high rate of postoperative complications such as anastomotic leakage (AL) and fistulas. Pre-operative sarcopenia as a loss of skeletal muscle mass and function is identified as a potential prognostic factor in determining the outcomes of oncological surgical resections for esophageal cancers. In this study, we evaluated the impact of body composition on postoperative complications in esophageal cancer surgery. Methods: In this cohort study, we analyzed patients’ body composition at the level of the third lumbar vertebra on CT scans before Ivor Lewis resections for esophageal cancers between January 2015 and December 2022. Patients with a skeletal muscle index (SMI) ≤ 38.5 cm2/m2 in women and ≤52.4 cm2/m2 in men were classified as sarcopenic. Postoperative complications were categorized following the Dindo–Clavien classification and included AL, postoperative pneumonia, length of hospital stay, and failure-to-rescue which were compared between the sarcopenic and non-sarcopenic patients. Results: From a group of 111 patients with Ivor Lewis esophagectomy, 70 patients (63.1%) were classified as sarcopenic based on the SMI and the previously published gender-specific cut-off values. AL occurred at 12.6% (5.6% in adenocarcinoma). Within the whole cohort, patients with AL had a significantly low SMI of 43.487 ± 8.088 vs. 48.668 ± 7.514; p = 0.012. Additionally, the SMI showed a negative correlation to the length of postoperative hospital stay (r = −0.204; p = 0.032; N = 111). The failure-to-rescue rate was higher in the group of sarcopenic patients (12.8% vs. 8%). Conclusions: Our data showed a correlation between SMI and AL. This effect could not be seen in gender-specific SMI. This study showed a lower failure-to-rescue rate in non-sarcopenic patients after Ivor Lewis esophagectomy. These findings underscore the crucial role of determining the preoperative nutritional and body composition status as measured by the preoperative CT scans.
Open AccessEffect of Preoperative Body Composition on Postoperative Anastomotic Leakage in Oncological Ivor Lewis Esophagectomy—A Retrospective Cohort Study
Background: Surgery for esophageal cancer has an associated high rate of postoperative complications such as anastomotic leakage (AL) and fistulas. Pre-operative sarcopenia as a loss of skeletal muscle mass and function is identified as a potential prognostic factor in determining the outcomes of oncological surgical resections for esophageal cancers. In this study, we evaluated the impact of body composition on postoperative complications in esophageal cancer surgery. Methods: In this cohort study, we analyzed patients’ body composition at the level of the third lumbar vertebra on CT scans before Ivor Lewis resections for esophageal cancers between January 2015 and December 2022. Patients with a skeletal muscle index (SMI) ≤ 38.5 cm2/m2 in women and ≤52.4 cm2/m2 in men were classified as sarcopenic. Postoperative complications were categorized following the Dindo–Clavien classification and included AL, postoperative pneumonia, length of hospital stay, and failure-to-rescue which were compared between the sarcopenic and non-sarcopenic patients. Results: From a group of 111 patients with Ivor Lewis esophagectomy, 70 patients (63.1%) were classified as sarcopenic based on the SMI and the previously published gender-specific cut-off values. AL occurred at 12.6% (5.6% in adenocarcinoma). Within the whole cohort, patients with AL had a significantly low SMI of 43.487 ± 8.088 vs. 48.668 ± 7.514; p = 0.012. Additionally, the SMI showed a negative correlation to the length of postoperative hospital stay (r = −0.204; p = 0.032; N = 111). The failure-to-rescue rate was higher in the group of sarcopenic patients (12.8% vs. 8%). Conclusions: Our data showed a correlation between SMI and AL. This effect could not be seen in gender-specific SMI. This study showed a lower failure-to-rescue rate in non-sarcopenic patients after Ivor Lewis esophagectomy. These findings underscore the crucial role of determining the preoperative nutritional and body composition status as measured by the preoperative CT scans.
- 10 July 2024
- Published by S. Karger AG in Visceral Medicine
- Vol. 40 (4) , 184-193
Reduction of Postoperative Complications in Pancreatic Surgery by Standardizing Perioperative Management: An Observational Cohort Study
Introduction: Resection for pancreatic malignancy remains the gold standard for cure. Postoperative morbidity continues to be high even after technical innovations. This study evaluates the effectiveness of a standard perioperative pancreatic oncological surgery step-by-step protocol in reducing organ-specific complications. Methods: In this observational cohort study, we analyzed the outcomes of oncologic pancreatic head resections from 2015 to 2022 after the implementation of a standard perioperative fail-safe protocol and compared these data with a historical cohort (2013–2014). In the study group, all patients were treated with preoperative limited mechanical bowel preparation, administration of a somatostatin analog, and a “pancreatic duct tube” in pancreatoduodenectomy. The primary outcome measure was the occurrence of postoperative organ-specific complications. Results: A total of 151 patients were included in this study. The rate of postoperative pancreatic fistula (grade B and C) in the fail-safe group was 4.2%. Other organ-specific complications as postoperative hemorrhage (2.5%) and delayed gastric emptying (9.2%) also occurred less frequent than before implementation of the fail-safe protocol. Conclusion: The use of this standardized fail-safe protocol for oncologic pancreatoduodenectomy can lead to a low postoperative morbidity with improved surgical outcomes.
- 10 July 2024
- Published by S. Karger AG in Visceral Medicine
- Vol. 40 (4) , 184-193
Reduction of Postoperative Complications in Pancreatic Surgery by Standardizing Perioperative Management: An Observational Cohort Study
Introduction: Resection for pancreatic malignancy remains the gold standard for cure. Postoperative morbidity continues to be high even after technical innovations. This study evaluates the effectiveness of a standard perioperative pancreatic oncological surgery step-by-step protocol in reducing organ-specific complications. Methods: In this observational cohort study, we analyzed the outcomes of oncologic pancreatic head resections from 2015 to 2022 after the implementation of a standard perioperative fail-safe protocol and compared these data with a historical cohort (2013–2014). In the study group, all patients were treated with preoperative limited mechanical bowel preparation, administration of a somatostatin analog, and a “pancreatic duct tube” in pancreatoduodenectomy. The primary outcome measure was the occurrence of postoperative organ-specific complications. Results: A total of 151 patients were included in this study. The rate of postoperative pancreatic fistula (grade B and C) in the fail-safe group was 4.2%. Other organ-specific complications as postoperative hemorrhage (2.5%) and delayed gastric emptying (9.2%) also occurred less frequent than before implementation of the fail-safe protocol. Conclusion: The use of this standardized fail-safe protocol for oncologic pancreatoduodenectomy can lead to a low postoperative morbidity with improved surgical outcomes.
- 17 April 2024
- Published by Elsevier in Surgical Oncology
- Vol. 54, 102080
Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort study
- 17 April 2024
- Published by Elsevier in Surgical Oncology
- Vol. 54, 102080
Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort study
- 29 April 2023
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 408 (1) , 1-9
The role of prophylactic administration of CPAP in general surgical wards after open visceral surgery in reducing postoperative pneumonia—a retrospective cohort study
Background Postoperative pneumonia is a main adverse event that causes increased postoperative morbidity and prolonged length of hospital stay leading to high postoperative mortality. Continuous positive airway pressure (CPAP) is a type of non-invasive ventilation for the delivery of a positive airway pressure during respiration. In this study, we evaluated the impact of postoperative prophylactic CPAP on prevention of pneumonia in patients after open visceral surgery. Methods In this observational cohort study, we compared the rates of postoperative pneumonia in patients who underwent open major visceral surgery from January 2018 till August 2020 in the study and control group. The study group had postoperative prophylactic sessions of CPAP for 15 min, 3–5 times a day and a repeated spirometer training was also performed in the general surgical ward. The control group received only the postoperative spirometer training as a prophylactic measure against postoperative pneumonia. The chi-square test was used to measure the relationships between categorical variables, and a binary regression analysis determined the correlation between independent and dependent variables. Results A total of 258 patients met the inclusion criteria who had open visceral surgery for various clinical illnesses. There were 146 men (56.6%) and 112 women with a mean age of 68.62 years. As many as 142 patients received prophylactic CPAP and they were grouped into the study group, whereas 116 patients without prophylactic CPAP were placed in the control group. Overall, the rate of postoperative pneumonia was significantly less in the study group (5.6% vs. 25.9% in the control group; p-value < 0.0001), which could be confirmed by the regression analysis (OR 0.118, CI 95% 0.047–0.295, p < 0.001). Conclusion Postoperative intermittent CPAP after open visceral surgery can be performed in a general surgical ward. Our study showed a significant association with a low rate of postoperative pneumonia, especially in high-risk patients. This leads to a significantly shorter postoperative hospital stay especially in high-risk patients after upper gastrointestinal surgery. Trial registration number DRKS00028988, 04.05.2022, retrospectively registered.
- 29 April 2023
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 408 (1) , 1-9
The role of prophylactic administration of CPAP in general surgical wards after open visceral surgery in reducing postoperative pneumonia—a retrospective cohort study
Background Postoperative pneumonia is a main adverse event that causes increased postoperative morbidity and prolonged length of hospital stay leading to high postoperative mortality. Continuous positive airway pressure (CPAP) is a type of non-invasive ventilation for the delivery of a positive airway pressure during respiration. In this study, we evaluated the impact of postoperative prophylactic CPAP on prevention of pneumonia in patients after open visceral surgery. Methods In this observational cohort study, we compared the rates of postoperative pneumonia in patients who underwent open major visceral surgery from January 2018 till August 2020 in the study and control group. The study group had postoperative prophylactic sessions of CPAP for 15 min, 3–5 times a day and a repeated spirometer training was also performed in the general surgical ward. The control group received only the postoperative spirometer training as a prophylactic measure against postoperative pneumonia. The chi-square test was used to measure the relationships between categorical variables, and a binary regression analysis determined the correlation between independent and dependent variables. Results A total of 258 patients met the inclusion criteria who had open visceral surgery for various clinical illnesses. There were 146 men (56.6%) and 112 women with a mean age of 68.62 years. As many as 142 patients received prophylactic CPAP and they were grouped into the study group, whereas 116 patients without prophylactic CPAP were placed in the control group. Overall, the rate of postoperative pneumonia was significantly less in the study group (5.6% vs. 25.9% in the control group; p-value < 0.0001), which could be confirmed by the regression analysis (OR 0.118, CI 95% 0.047–0.295, p < 0.001). Conclusion Postoperative intermittent CPAP after open visceral surgery can be performed in a general surgical ward. Our study showed a significant association with a low rate of postoperative pneumonia, especially in high-risk patients. This leads to a significantly shorter postoperative hospital stay especially in high-risk patients after upper gastrointestinal surgery. Trial registration number DRKS00028988, 04.05.2022, retrospectively registered.
- Open Access
- 11 March 2023
- Published by Springer Nature in Perioperative Medicine
- Vol. 12 (1) , 1-12
Safety profile of a multimodal fail-safe model to minimize postoperative complications in oncologic colorectal resections—a cohort study
Background: Despite innovations in surgical techniques, major complications following colorectal surgery still lead to a significant morbidity and mortality. There is no standard protocol for perioperative management of patients with colorectal cancer. This study evaluates the effectiveness of a multimodal fail-safe model in minimizing severe surgical complications following colorectal resections. Methods: We compared major complications in patients with colorectal cancers who underwent surgical resections with anastomosis during 2013–2014 (control group) with patients treated during 2015–2019 (fail-safe group). The fail-safe group had preoperative bowel preparation and a perioperative single dose of antibiotics, on-table bowel irrigation and early sigmoidoscopic assessment of anastomosis in rectal resections. A standard surgical technique for tension-free anastomosis was adapted in the fail-safe approach. The chi-square test measured relationships between categorical variables, t-test estimated the probability of differences, and the multivariate regression analysis determined the linear correlation among independent and dependent variables. Results: A total of 924 patients underwent colorectal operations during the study period; however, 696 patients had surgical resections with primary anastomoses. There were 427 (61.4%) laparoscopic and 230 (33.0%) open operations, while 39 (5.6%) laparoscopic procedures were converted. Overall, the rate of major complications (Dindo-Clavien grade IIIb–V) significantly reduced from 22.6% for the control group to 9.8% for the fail-safe group (p < 0.0001). Major complications mainly occurred due to non-surgical reasons such as pneumonia, heart failure, or renal dysfunction. The rates of anastomotic leakage (AL) were 11.8% (22/186) and 3.7% (n = 19/510) for the control and fail-safe groups, respectively (p < 0.0001). Conclusion: We report an effective multimodal fail-safe protocol for colorectal cancer during the pre-, peri-, and postoperative period. The fail-safe model showed less postoperative complications even for low rectal anastomosis. This approach can be adapted as a structured protocol during the perioperative care of patients for colorectal surgery. Trial registration: This study was registered in the German Clinical Trial Register (Study ID: DRKS00023804).
- 11 March 2023
- Published by Springer Nature in Perioperative Medicine
- Vol. 12 (1) , 1-12
Open AccessSafety profile of a multimodal fail-safe model to minimize postoperative complications in oncologic colorectal resections—a cohort study
Background: Despite innovations in surgical techniques, major complications following colorectal surgery still lead to a significant morbidity and mortality. There is no standard protocol for perioperative management of patients with colorectal cancer. This study evaluates the effectiveness of a multimodal fail-safe model in minimizing severe surgical complications following colorectal resections. Methods: We compared major complications in patients with colorectal cancers who underwent surgical resections with anastomosis during 2013–2014 (control group) with patients treated during 2015–2019 (fail-safe group). The fail-safe group had preoperative bowel preparation and a perioperative single dose of antibiotics, on-table bowel irrigation and early sigmoidoscopic assessment of anastomosis in rectal resections. A standard surgical technique for tension-free anastomosis was adapted in the fail-safe approach. The chi-square test measured relationships between categorical variables, t-test estimated the probability of differences, and the multivariate regression analysis determined the linear correlation among independent and dependent variables. Results: A total of 924 patients underwent colorectal operations during the study period; however, 696 patients had surgical resections with primary anastomoses. There were 427 (61.4%) laparoscopic and 230 (33.0%) open operations, while 39 (5.6%) laparoscopic procedures were converted. Overall, the rate of major complications (Dindo-Clavien grade IIIb–V) significantly reduced from 22.6% for the control group to 9.8% for the fail-safe group (p < 0.0001). Major complications mainly occurred due to non-surgical reasons such as pneumonia, heart failure, or renal dysfunction. The rates of anastomotic leakage (AL) were 11.8% (22/186) and 3.7% (n = 19/510) for the control and fail-safe groups, respectively (p < 0.0001). Conclusion: We report an effective multimodal fail-safe protocol for colorectal cancer during the pre-, peri-, and postoperative period. The fail-safe model showed less postoperative complications even for low rectal anastomosis. This approach can be adapted as a structured protocol during the perioperative care of patients for colorectal surgery. Trial registration: This study was registered in the German Clinical Trial Register (Study ID: DRKS00023804).
- Open Access
Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers
Background: Pseudomyxoma peritonei (PMP) is a rare peritoneal condition where mucus-secreting tumorous cells progressively produce a thick, gelatin-like substance. The prognosis of patients with PMP is determined by the degree of cellularity within the mucin (low-grade (LAMN) vs. high-grade (HAMN) histologic features) and by the extent of the disease. Methods: Prognostic relevance of tumor markers CA19-9 and CEA, gender, Peritoneal Cancer Index (PCI), and completeness of cytoreduction (CC) after cytoreductive surgery were evaluated on 193 consecutive PMP patients, based on a retrospective analysis of prospectively gathered data from a German tertial referral center. Results: We demonstrated that low PCI, CC0 status, low-grade histology, and female gender were independent positive prognostic factors for both overall survival (OS) and progression-free survival (PFS). Furthermore, LAMN patients with achieved CC0 status show significantly better OS and PFS compared to those with CC1 status (p = 0.0353 and p = 0.0026 respectively). In contrast, the duration and drug of hyperthermic intraperitoneal chemotherapy (HIPEC) were not prognostic in any comparison. Increased CA19-9 and CEA levels were significantly associated with HAMN cases, but also predicted recurrence in patients with low-grade histologies. Conclusion: Our study confirmed the prognostic role of tumor markers and emphasized the importance of CC status and PCI in a large cohort of PMP- and LAMN patients.
Open AccessPrognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers
Background: Pseudomyxoma peritonei (PMP) is a rare peritoneal condition where mucus-secreting tumorous cells progressively produce a thick, gelatin-like substance. The prognosis of patients with PMP is determined by the degree of cellularity within the mucin (low-grade (LAMN) vs. high-grade (HAMN) histologic features) and by the extent of the disease. Methods: Prognostic relevance of tumor markers CA19-9 and CEA, gender, Peritoneal Cancer Index (PCI), and completeness of cytoreduction (CC) after cytoreductive surgery were evaluated on 193 consecutive PMP patients, based on a retrospective analysis of prospectively gathered data from a German tertial referral center. Results: We demonstrated that low PCI, CC0 status, low-grade histology, and female gender were independent positive prognostic factors for both overall survival (OS) and progression-free survival (PFS). Furthermore, LAMN patients with achieved CC0 status show significantly better OS and PFS compared to those with CC1 status (p = 0.0353 and p = 0.0026 respectively). In contrast, the duration and drug of hyperthermic intraperitoneal chemotherapy (HIPEC) were not prognostic in any comparison. Increased CA19-9 and CEA levels were significantly associated with HAMN cases, but also predicted recurrence in patients with low-grade histologies. Conclusion: Our study confirmed the prognostic role of tumor markers and emphasized the importance of CC status and PCI in a large cohort of PMP- and LAMN patients.
- Open Access
- 1 July 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 896151
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine – A Prospective Observational Study
Background: Since the introduction of various vaccines against SARS-CoV-2 at the end of 2020, infection rates have continued to climb worldwide. This led to the establishment of a third dose vaccination in several countries, known as a booster. To date, there has been little real-world data about the immunological effect of this strategy.Methods: We compared the humoral- and cellular immune response before and after the third dose of BioNTech/Pfizer vaccine BNT162b2, following different prime-boost regimen in a prospective observational study. Humoral immunity was assessed by determining anti-SARS-CoV-2 binding antibodies using a standardized quantitative assay. In addition, neutralizing antibodies were measured using a commercial surrogate ELISA-assay. Interferon-gamma release was measured after stimulating blood-cells with SARS-CoV-2 specific peptides using a commercial assay to evaluate the cellular immune response.Results: We included 243 health-care workers who provided blood samples and questionnaires pre- and post- third vaccination. The median antibody level increased significantly after the third vaccination dose to 2663.1 BAU/ml vs. 101.4 BAU/ml (p < 0.001) before administration of the booster dose. This was also detected for neutralizing antibodies with a binding inhibition of 99.68% ± 0.36% vs. 69.06% ± 19.88% after the second dose (p < 0.001). 96.3% of the participants showed a detectable T-cell-response after the booster dose with a mean interferon-gamma level of 2207.07 mIU/ml ± 1905 mIU/ml.Conclusion: This study detected a BMI-dependent antibody increase after the third dose of BNT162b2 following different vaccination protocols. All participants showed a significant increase in their immune response. This, in combination with the low rate of post-vaccination-symptoms underlines the potential beneficial effect of a BNT162b2-booster dose.
- 1 July 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 896151
Open AccessCellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine – A Prospective Observational Study
Background: Since the introduction of various vaccines against SARS-CoV-2 at the end of 2020, infection rates have continued to climb worldwide. This led to the establishment of a third dose vaccination in several countries, known as a booster. To date, there has been little real-world data about the immunological effect of this strategy.Methods: We compared the humoral- and cellular immune response before and after the third dose of BioNTech/Pfizer vaccine BNT162b2, following different prime-boost regimen in a prospective observational study. Humoral immunity was assessed by determining anti-SARS-CoV-2 binding antibodies using a standardized quantitative assay. In addition, neutralizing antibodies were measured using a commercial surrogate ELISA-assay. Interferon-gamma release was measured after stimulating blood-cells with SARS-CoV-2 specific peptides using a commercial assay to evaluate the cellular immune response.Results: We included 243 health-care workers who provided blood samples and questionnaires pre- and post- third vaccination. The median antibody level increased significantly after the third vaccination dose to 2663.1 BAU/ml vs. 101.4 BAU/ml (p < 0.001) before administration of the booster dose. This was also detected for neutralizing antibodies with a binding inhibition of 99.68% ± 0.36% vs. 69.06% ± 19.88% after the second dose (p < 0.001). 96.3% of the participants showed a detectable T-cell-response after the booster dose with a mean interferon-gamma level of 2207.07 mIU/ml ± 1905 mIU/ml.Conclusion: This study detected a BMI-dependent antibody increase after the third dose of BNT162b2 following different vaccination protocols. All participants showed a significant increase in their immune response. This, in combination with the low rate of post-vaccination-symptoms underlines the potential beneficial effect of a BNT162b2-booster dose.